University of California appeals patent setback, extending CRISPR fight – BioPharma Dive
|
University of California appeals patent setback, extending CRISPR fight
BioPharma Dive In mid-February, the Patent Trial and Appeal Board (PTAB) ruled that key patents held by the Broad on CRISPR-Cas9 do not overlap with competing claims from UC, effectively supporting the Broad's existing patents for use of the technology in eukaryotic … |
